We are live on
!
Find out more
SC
Searle & Co Portfolio holdings
AUM
$398M
1-Year Est. Return
22.87%
This Fund
S&P 500
This Quarter
Est. Return
+6.97%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$401M
AUM Growth
-$25.8M
(-6%)
Cap. Flow
-$49.2M
Cap. Flow
% of AUM
-12.26%
Top 10 Holdings %
Top 10 Hldgs %
43.45%
Holding
192
New
8
Increased
8
Reduced
73
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$4.91M |
| 2 |
BNT
Brookfield Wealth Solutions
BNT
|
+$1.07M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$1.04M |
| 4 |
iShares Treasury Floating Rate Bond ETF
TFLO
|
+$212K |
| 5 |
SA
Seabridge Gold
SA
|
+$195K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$8.99M |
| 2 |
Procter & Gamble
PG
|
+$8.52M |
| 3 |
FITB
Fifth Third Bancorp
FITB
|
+$6.02M |
| 4 |
Eli Lilly
LLY
|
+$4.81M |
| 5 |
Merck
MRK
|
+$2.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.45% |
| 2 | Technology | 20.8% |
| 3 | Healthcare | 12.73% |
| 4 | Industrials | 11.09% |
| 5 | Consumer Staples | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FITB
176
Fifth Third Bancorp
FITB
$52.6B
| – | – |
-165,037
| Closed | -$6.02M |
|
177
TechnipFMC
FTI
$28.7B
| – | – |
-10,000
| Closed | -$262K |
|
178
Gilead Sciences
GILD
$167B
| – | – |
-6,750
| Closed | -$463K |
|
179
GSK
GSK
$104B
| – | – |
-7,224
| Closed | -$278K |
|
180
iShares 3-7 Year Treasury Bond ETF
IEI
$18.2B
| – | – |
-7,759
| Closed | -$896K |
|
181
Milestone Scientific
MLSS
$38.7M
| – | – |
-10,000
| Closed | -$6.83K |
|
182
Novartis
NVS
$293B
| – | – |
-1,900
| Closed | -$202K |
|
183
Public Storage
PSA
$55.8B
| – | – |
-800
| Closed | -$230K |
|
184
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
| – | – |
-11,500
| Closed | -$939K |
|
185
Truist Financial
TFC
$65.4B
| – | – |
-8,644
| Closed | -$336K |
|
186
US Bancorp
USB
$98.4B
| – | – |
-39,240
| Closed | -$1.56M |
|
187
Petco
WOOF
$760M
| – | – |
-20,000
| Closed | -$75.6K |
|
188
State Street SPDR S&P Biotech ETF
XBI
$10.4B
| – | – |
-6,000
| Closed | -$556K |
|
189
Yum China
YUMC
$15.1B
| – | – |
-39,115
| Closed | -$1.21M |
|
190
Zimmer Biomet
ZBH
$17.6B
| – | – |
-2,000
| Closed | -$217K |
|
Similar funds
CF
VC
DL
ECA
BWM
MHC
LSA
THL
Searle & Co's Q3 2024 Portfolio in Review
As of Q3 2024, Searle & Co held 192 positions worth $401M, down 6% from $427M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Searle & Co withdrew a net $49.2M in Q3 2024, closing 21 positions and reducing 73 holdings. Its most notable exit was Fifth Third Bancorp, an estimated $6.02M position sold in full.
By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Searle & Co opened a new position in Brookfield Wealth Solutions worth $1.2M.
- Searle & Co's largest Q3 2024 buy was Brookfield Wealth Solutions: 33,981 shares worth $1.2M.
- Searle & Co added most to JPMorgan Chase in Q3 2024, an estimated $4.91M increase.
- Searle & Co's biggest Q3 2024 reduction was ExxonMobil, cutting an estimated $8.99M.
- Searle & Co fully exited Fifth Third Bancorp in Q3 2024, selling an estimated $6.02M.
- Searle & Co's ten largest holdings make up 43% of its $401M portfolio in Q3 2024.
- Searle & Co opened 8 new positions and closed 21 in Q3 2024.
- Searle & Co's portfolio value fell 6% quarter-over-quarter to $401M.
Based on Searle & Co's 13F filing for Q3 2024, filed 22 Oct 2024.